Vyas KP[au] - Search Results

Year	Number of Results
1978	1
1981	2
1982	3
1983	3
1984	3
1985	1
1987	1
1990	7
1991	2
1993	2
1994	1
1995	1
1996	3
1997	3
1998	1
1999	5
2000	6
2001	2
2002	1
2003	2
2024	0

1

Pharmacokinetics of intravenous alendronate.

Cocquyt V, Kline WF, Gertz BJ, Van Belle SJ, Holland SD, DeSmet M, Quan H, Vyas KP, Zhang KE, De Grève J, Porras AG. Cocquyt V, et al. Among authors: vyas kp. J Clin Pharmacol. 1999 Apr;39(4):385-93. doi: 10.1177/00912709922007958. J Clin Pharmacol. 1999. PMID: 10197297 Clinical Trial.

2

Regioselectivity and stereoselectivity in the metabolism of HMG-CoA reductase inhibitors.

Vyas KP, Kari PH, Pitzenberger SM. Vyas KP, et al. Biochem Biophys Res Commun. 1990 Feb 14;166(3):1155-62. doi: 10.1016/0006-291x(90)90987-x. Biochem Biophys Res Commun. 1990. PMID: 2306236

3

In vitro and in vivo studies on the metabolism of tirofiban.

Vickers S, Theoharides AD, Arison B, Balani SK, Cui D, Duncan CA, Ellis JD, Gorham LM, Polsky SL, Prueksaritanont T, Ramjit HG, Slaughter DE, Vyas KP. Vickers S, et al. Among authors: vyas kp. Drug Metab Dispos. 1999 Nov;27(11):1360-6. Drug Metab Dispos. 1999. PMID: 10534322

4

In vitro and in vivo biotransformation of simvastatin, an inhibitor of HMG CoA reductase.

Vickers S, Duncan CA, Vyas KP, Kari PH, Arison B, Prakash SR, Ramjit HG, Pitzenberger SM, Stokker G, Duggan DE. Vickers S, et al. Among authors: vyas kp. Drug Metab Dispos. 1990 Jul-Aug;18(4):476-83. Drug Metab Dispos. 1990. PMID: 1976071

5

Effect of inhibitors of alpha-naphthylisothiocyanate-induced hepatotoxicity on the in vitro metabolism of alpha-naphthylisothiocyanate.

Traiger GJ, Vyas KP, Hanzlik RP. Traiger GJ, et al. Among authors: vyas kp. Chem Biol Interact. 1985 Jan;52(3):335-45. doi: 10.1016/0009-2797(85)90028-6. Chem Biol Interact. 1985. PMID: 2982508

6

Disposition and pharmacokinetics of the antimigraine drug, rizatriptan, in humans.

Vyas KP, Halpin RA, Geer LA, Ellis JD, Liu L, Cheng H, Chavez-Eng C, Matuszewski BK, Varga SL, Guiblin AR, Rogers JD. Vyas KP, et al. Drug Metab Dispos. 2000 Jan;28(1):89-95. Drug Metab Dispos. 2000. PMID: 10611145

7

Metabolism of MK-499, a class III antiarrhythmic agent, in rats and dogs.

Vickers S, Duncan CA, Slaughter DE, Arison BH, Greber T, Olah TV, Vyas KP. Vickers S, et al. Among authors: vyas kp. Drug Metab Dispos. 1998 May;26(5):388-95. Drug Metab Dispos. 1998. PMID: 9571219

8

Rizatriptan, a novel 5-HT1B/1D agonist for migraine: single- and multiple-dose tolerability and pharmacokinetics in healthy subjects.

Goldberg MR, Lee Y, Vyas KP, Slaughter DE, Panebianco D, Ermlich SJ, Shadle CR, Brucker MJ, McLoughlin DA, Olah TV. Goldberg MR, et al. Among authors: vyas kp. J Clin Pharmacol. 2000 Jan;40(1):74-83. doi: 10.1177/00912700022008595. J Clin Pharmacol. 2000. PMID: 10631625 Clinical Trial.

9

HMG-CoA reductase inhibitor-induced myopathy in the rat: cyclosporine A interaction and mechanism studies.

Smith PF, Eydelloth RS, Grossman SJ, Stubbs RJ, Schwartz MS, Germershausen JI, Vyas KP, Kari PH, MacDonald JS. Smith PF, et al. Among authors: vyas kp. J Pharmacol Exp Ther. 1991 Jun;257(3):1225-35. J Pharmacol Exp Ther. 1991. PMID: 1904494

10

Substituent effects on the hepatotoxicity of thiobenzamide derivatives in the rat.

Hanzlik RP, Vyas KP, Traiger GJ. Hanzlik RP, et al. Among authors: vyas kp. Toxicol Appl Pharmacol. 1978 Dec;46(3):685-94. doi: 10.1016/0041-008x(78)90313-7. Toxicol Appl Pharmacol. 1978. PMID: 746555 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

50 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

50 results

Results by year